26 ML ustekinumab-srlf 5 MG/ML Injection [Imuldosa]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
26 ML ustekinumab-srlf 5 MG/ML Injection [Imuldosa]
5 MG/ML · Injection · injection
A form of ustekinumab-srlf →
26 ML ustekinumab-srlf 5 MG/ML Injection [Imuldosa] — Interleukin inhibitors. Strength, form, class, interactions & more.
![26 ML ustekinumab-srlf 5 MG/ML Injection [Imuldosa]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2539a6cf-0fe5-1565-e063-6294a90a3618&name=130-mg-26-ml-carton.jpg)
Active ingredient
Classification
Interleukin inhibitorsInterleukin-12 Antagonist
Drug interactions
Ustekinumab may interact with certain drugs and therapies, particularly immunosuppressive agents and allergen immunotherapy.
- moderateimmunosuppressive agents — Safety and efficacy not evaluated in combination with ustekinumab.
- moderatemethotrexate (MTX) — Did not appear to influence the safety or efficacy of ustekinumab.
- moderateCYP450 substrates — Consider monitoring for therapeutic effect or drug concentration upon initiation or discontinuation of ustekinumab.
- moderateallergen immunotherapy — May decrease the protective effect of allergen immunotherapy, increasing the risk of allergic reactions.
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication